Table III.
Probability values for main effect of gene and gene × exercise interactions relative to change in body composition
| %TBF | AbFat (kg) | LST (kg) | ||
|---|---|---|---|---|
|
| ||||
| Model 1 | ||||
| ADRA2B | 0.91 | 0.95 | 0.98 | |
| Exercise | 0.004 | 0.02 | <0.0001 | |
| ADRA2B × exercise | 0.71 | 0.90 | 0.02 | |
|
| ||||
| Adjusted R2 | 3% | 1% | 22% | |
|
| ||||
| Model 2 | ||||
| ADRB3 | 0.13 | 0.52 | 0.19 | |
| Exercise | 0.001 | 0.02 | <0.0001 | |
| ADRB3 × exercise | 0.13 | 0.38 | 0.12 | |
|
| ||||
| Adjusted R2 | 5% | 3% | 21% | |
|
| ||||
| Model 3 | ||||
| ADRB2 | 0.56 | 0.74 | 0.65 | |
| Exercise | 0.002 | 0.01 | <0.0001 | |
| ADRB2 × exercise | 0.47 | 0.17 | 0.02 | |
|
| ||||
| Adjusted R2 | 3% | 3% | 22% | |
Percent total body fat, %TBF; abdominal fat, AbFat; lean soft tissue, LST. Univariate (GLM) model fixed factors were exercise and genotype. Covariates included: age, hormone therapy status, and baseline value of respective body composition outcome.